Helus Pharma director reports 156K shares via firm
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Helus Pharma Inc. director Eric Hoskins reported holdings dated October 13, 2026: 156,000 Common Shares held by Lucky Square Holdings Inc., which the associated footnote identifies as owned and controlled by him; 1,316 Common Shares held directly; and 1,316 Common Shares held by his spouse. Lucky Square also holds warrants covering 30,263 Common Shares, with a US$6.79 exercise price converted from C$9.50 at C$1.4 = US$1.00 and an expiration date of November 15, 2030.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants F2 | -- | -- | -- |
| holding | Common Shares F1 | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (2)
- F1. Held by Lucky Square Holdings Inc., a corporation owned and controlled by the reporting person.
- F2. Exercise price converted from Canadian exercise price of C$9.50 using an exchange rate of C$1.4 = US$1.00.
Key Figures
Key Terms
Warrants financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of the HELP warrants held by Lucky Square Holdings Inc.?
AI-generated analysis. How Rhea-AI works. Not financial advice.